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Abstract
Objective To use arterial spin labelling to investigate differences in perfusion in mild cognitive impairment with Lewy bod-
ies (MCI-LB) compared to Alzheimer type MCI (MCI-AD) and healthy controls.
Methods We obtained perfusion images on 32 MCI-LB, 30 MCI-AD and 28 healthy subjects of similar age. Perfusion rela-
tive to cerebellum was calculated, and we aimed to examine differences in relative perfusion between MCI-LB and the other 
groups. This included whole brain voxelwise comparisons, as well as using predefined region-of-interest ratios of medial 
occipital to medial temporal, and posterior cingulate to precuneus. Differences in occipital perfusion in eyes open vs eyes 
closed conditions were also examined.
Results Compared to controls, the MCI-LB showed reduced perfusion in the precuneus, parietal, occipital and fusiform 
gyrus regions. In our predefined regions, the ratio of perfusion in occipital/medial temporal was significantly lower, and the 
posterior cingulate/precuneus ratio was significantly higher in MCI-LB compared to controls. Overall, the occipital perfu-
sion was greater in the eyes open vs closed condition, but this did not differ between groups.
Conclusion We found patterns of altered perfusion in MCI-LB which are similar to those seen in dementia with Lewy bodies, 
with reduction in posterior parietal and occipital regions, but relatively preserved posterior cingulate.
Keywords Mild cognitive impairment · Magnetic resonance imaging · Perfusion imaging · Arterial spin labelling · Lewy 
body disease
Introduction
There is increased recognition that identification and treat-
ment of dementia should be performed as early as possible in 
the disease process to optimise chances of treatment success, 
and to be able to offer specific healthcare advice to patients 
and care givers. As such, there has been a research focus on 
earlier, prodromal stages, of dementia such as the condi-
tion of mild cognitive impairment (MCI), which represents 
a high risk state for progression to dementia. Whilst most 
previous work and diagnostic criteria for MCI has focussed 
around it as a risk state for progression to Alzheimer’s dis-
ease, criteria for mild cognitive impairment with Lewy bod-
ies (MCI-LB) have recently been published as part of the 
recognition that prodromal stages of dementia with Lewy 
bodies can also be identified [1].
Imaging of brain metabolism, either through FDG-PET, 
perfusion SPECT or arterial spin labelled MRI (ASL) 
[2–4] is often done as part of the investigation in dementia 
patients. Studies with FDG-PET in MCI-LB have found a 
hypometabolic pattern similar to that seen in dementia with 
Lewy bodies (DLB) [5], with parieto-occipital hypometab-
olism [6], and relative preservation of posterior cingulate 
(cingulate island sign) [7]. Compared with FDG-PET, ASL 
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has the advantage of being cheaper, non-radioactive, and 
can be done alongside other MR imaging; Dolui [8] com-
pared ASL and FDG in MCI-AD and age matched controls 
and found similarities between the two techniques, with the 
hypometabolism patterns in MCI-AD similar to those seen 
in AD dementia. There have been few studies using per-
fusion imaging ASL in MCI-LB. Roquet et al. found mild 
reductions in the temporal and insula gyrus [9], and some 
studies have compared Parkinson’s disease with and with-
out mild cognitive impairment [10], finding reduced precu-
neus perfusion. In our previous paper comparing AD and 
DLB with FDG imaging [11], we found that both the ratio 
of posterior cingulate cortex (PCC) to precuneus and ratio 
of medial occipital to medial temporal lobe (MTL) metabo-
lism were useful in distinguishing between the diseases. We 
aimed to investigate this in MCI using ASL.
In a previous article investigating FDG-PET in early stage 
PD [12], we found parieto-occipital reductions in PD com-
pared to age matched controls. That study was performed 
with participants having their eyes open. In healthy sub-
jects with normal vision, occipital metabolism is increased 
on opening eyes, owing to the increased stimulation of 
the occipital lobe. We hypothesised that due to changes in 
their visual system [13], patients with Lewy body disease 
might have a diminished occipital response to opening their 
eyes, which might underlie this occipital hypometabolism 
in the eyes open state. In this current study, we acquired 
ASL images in both the eyes open and closed conditions to 
investigate this further in MCI-LB.
In this study, we aimed to investigate blood perfusion 
measured with ASL in patients with MCI-LB and MCI-AD, 
in comparison to each other and to healthy subjects of the 
same age, to verify the extent to which changes seen in DLB 
are present in MCI-LB and thus to indicate if ASL may be 
of clinical use in the diagnosis of MCI-LB.
Our hypotheses were:
1. The posterior cingulate/precuneus ratio would be 
increased in MCI-LB relative to MCI-AD and controls.
2. The medial occipital/MTL ratio would be decreased in 
MCI-LB relative to MCI-AD and controls.
3. Voxelwise analysis would show decreased perfusion 
in the occipital and lateral parietal regions in MCI-LB 
compared with MCI-AD and controls.
4. Blood flow in the occipital lobe would increase in all 
subjects on eyes open vs closed, but that this would be 
less marked in MCI-LB.
Methods
Participants
This study included participants over the age of 60 with a 
diagnosis of mild cognitive impairment (MCI) who were 
recruited from local memory services in the north east of 
England between April 2016 and Sept 2019. In addition to 
MCI, participants reported one or more clinical symptoms 
supportive (but not specific) to a diagnosis of LB disease 
(e.g. sleep disturbance, mood changes, or autonomic symp-
toms) or any of the core LB clinical features (visual hal-
lucinations, cognitive fluctuations, REM sleep behaviour 
disorder, parkinsonism). Following informed consent, par-
ticipants underwent interview, clinical assessment and neu-
rological examination by a medical doctor (RD, SL).
The MDS Unified Parkinson’s Disease Rating Scale-
Motor Examination (UPDRS-III), Epworth Sleepiness Scale 
(ESS), and Geriatric Depression Scale (GDS) were admin-
istered to patients. The Instrumental Activities of Daily 
Living (IADL) scale, Neuropsychiatric Inventory (NPI), 
North-East Visual Hallucinations Inventory (NEVHI), Mayo 
Sleep Questionnaire (MSQ), Dementia Cognitive Fluctua-
tion Scale (DCFS), and Clinician Assessment of Fluctuation 
(CAF) were administered to informants. Clinical Dementia 
Rating scale (CDR) and Cumulative Illness Rating Scale 
for Geriatrics (CIRS-G) were completed on the basis of the 
clinical history and other research assessments. A detailed 
neuropsychological evaluation was also carried out similar 
to that reported previously [14] which included the ACE-
R, a 100-point cognitive screening test from which Mini-
Mental State Examination (MMSE) score was derived. All 
participants were offered imaging with 123I-metaiodoben-
zylguanidine (MIBG) myocardial scintigraphy and 123I-N-
3-fluoropropyl-2beta-carbomethoxy-3beta-4-iodophenyl 
tropane (FP-CIT) SPECT. FP-CIT images were rated as 
normal/abnormal by an experienced consensus panel blind 
to clinical information [15]. For MIBG, the heart to medi-
astinum ratio (HMR) was calculated from manually drawn 
regions of interest, and scans were classified as normal/
abnormal using a predefined HMR cut off of 1.85 based on 
local control data [16].
Diagnosis of MCI was confirmed by a consensus panel 
of three experienced old-age psychiatrists according to NIA-
AA criteria [17] after reviewing medical records. This was 
based on evidence of minimal functional impairment and 
a CDR of 0 or 0.5, and a history of subjective and objec-
tive cognitive decline on assessment, originally identified 
in the health service. We excluded those with dementia or 
only subjective impairment as well as those with vascular or 
frontotemporal etiologies, or parkinsonism pre-dating cog-
nitive impairment by more than one year. To determine the 
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aetiology of the MCI, the presence or absence of core Lewy 
body (LB) symptoms were rated by the panel blind to imag-
ing findings. Core features were determined in accordance 
with the fourth consensus criteria for DLB [18] which is 
consistent with the recently published MCI-LB criteria [1].
Participants all had baseline research assessments and 
most had annual review data available by the time of data 
locking. Annual review data was used for the consensus 
panel diagnosis where available. A diagnosis of probable 
MCI with Lewy bodies (MCI-LB) was given if a patient had 
two or more core Lewy body symptoms or one core symp-
tom in addition to a positive FP-CIT or MIBG scan. A diag-
nosis of MCI with probable Alzheimer’s disease (MCI-AD) 
was given to patients who had no core Lewy body symptoms 
and negative FP-CIT and MIBG findings. CSF and imag-
ing biomarkers were not used in the diagnosis of MCI-AD, 
therefore the MCI-AD fulfilled the NIA-AA ‘Core Clinical 
Criteria’ for MCI-AD.
According to these criteria, we performed MRI scans on 
39 participants diagnosed with probable MCI-LB and 37 
diagnosed with MCI-AD. Healthy controls (N = 31) were 
recruited from friends and relatives of the patients and from 
a local research register and had no history of psychiatric or 
neurological illness, no evidence of cognitive decline and 
MR scans within normal limits. We also acquired MRI scans 
on 18 subjects who had only one Lewy body core feature or 
positive biomarker at most recent review. These participants 
were not included in the analysis presented here as our focus 
was on probable MCI-LB vs MCI-AD. Figure 1 shows the 
recruitment and exclusion flowchart.
Written informed consent was obtained from all partici-
pants prior to study participation and the study was approved 
by the National Research Ethics Service Committee North 
East—Newcastle & North Tyneside 2 (Research Ethics 
Committee Identification Number 15/NE/0420).
Imaging
Imaging was performed on a 3 T Philips Intera Achieva 
scanner. Structural images were acquired with a magneti-
zation prepared rapid gradient echo (MPRAGE) sequence, 
sagittal acquisition, echo time 4.6 ms, repetition time 8.3 ms, 
inversion time 1250 ms, flip angle = 8°, SENSE factor = 2, 
in-plane field of view 240 × 240 mm with slice thickness 
1.0 mm, yielding a voxel size of 1.0 × 1.0 × 1.0  mm3. A 
FLAIR (fluid attenuated inversion recovery) sequence was 
Fig. 1  Flow chart showing exclusions and number of MRI scans in the patient groups
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also obtained with repetition time 11,000 ms, inversion time 
2800 ms, echo time 125 ms voxel size 0.94 × 0.94 mm, 50 
slices with thickness 3 mm.
Perfusion scans were acquired in eyes closed then eyes 
open conditions, each lasting 4 min with a background 
suppressed pseudo continuous arterial spin labelling 
(pCASL) with a spin echo- echo planar image (repetition 
time = 4 s, echo time 13 ms, label duration = 1.65 s, post 
label delay = 1.6 s, slice thickness = 5 mm). Apart from the 
comparison of eyes open vs eyes closed, all other analyses 
were done on the average of both ASL acquisitions.
Image processing
FLAIR images were co-registered with the T1 weighted 
structural image, and areas of white matter hyperintensity 
(WMH) identified using in house developed code based on 
SPM [19]. The ASL images were converted to relative per-
fusion maps using the FSL basil tool (https ://fsl.fmrib .ox.
ac.uk/fsl/fslwi ki/BASIL ). We used SPM12 (https ://www.
fil.ion.ucl.ac.uk/spm/) to co-register the ASL images to the 
structural T1 images, which were normalised to standard 
space using the Dartel toolbox. The Dartel spatial trans-
formation was applied to the perfusion maps which were 
written in the standard Montreal Neurological Institute 
152 space with a resolution of 1.5 × 1.5 × 1.5 mm. Gauss-
ian smoothing of 8 mm was applied. For region-of-interest 
analysis, we extracted the mean perfusion values of the 
medial occipital lobe from the visual area regions V1 and 
V2 from the anatomy toolbox [20, 21] and used regions of 
medial temporal lobe, posterior cingulate, precuneus and 
cerebellum, derived from the AAL atlas [22] as described 
previously [11]. The mean signal intensity in the cerebel-
lum was used to normalise values to give rCBF in the SPM 
analyses. The anatomical description of significant clusters 
was determined utilising the anatomy toolbox.
ASL scans were not obtained on 1 control due to techni-
cal problems, 1 MCI-AD and 1 MCI-LB who did not tolerate 
the whole scan period, two subjects (1 MCI-AD, 1 MCI-LB) 
were excluded due to incomplete scan coverage of the brain. 
We excluded those with > 2 mm motion (1 control, 2 MCI-
AD, 3 MCI-LB). We also visually inspected all scans (blind 
to group) and excluded a further 1 control, 3 MCI-AD, 2 
MCI-LB due to poor quality images including those with 
low signal to noise, unexpected asymmetries, and abnor-
mally high signal in the main blood vessels.
Statistics
For image voxelwise comparisons, we used the general lin-
ear model in SPM, thresholded voxelwise at p < 0.001 uncor-
rected, and then clusters which were significant after family 
wise error correction (p < 0.05) were reported. R version 
3.6.3 was used for all other statistical analysis. ANOVA was 
used to compare groups, followed (where significant) by 
Tukey HSD test to determine between group differences. T 
tests were done without assuming equal variance. Chi square 
or Fisher’s exact tests were done to compare categorical vari-
ables. Correlations with clinical variables were done with 
Spearman’s rho. For WMH volumes, we calculated the log 
of the ratio of WMH to total brain volume to render the data 
more normally distributed. Table 1 gives the mean volume 
in  mm3 for ease of interpretation, but the t-test was done on 
the logged values.
Results
There were 32 MCI-LB, 30 MCI-AD and 28 controls with 
ASL perfusion scans included in the analysis. Table 1 shows 
the demographics of these subjects. In keeping with the 
disease profile, most of the MCI-LB subjects were male. 
Results from these participants have been previously pub-
lished [23], including further details of the cognitive and 
clinical characteristics of the patients.
Table 2 shows the mean values of perfusion for the PCC/
precuneus ratio. This was highest in the MCI-LB group, 
which was significantly different to the control group, but 
there were no significant differences between the two MCI 
groups. Table 2 also shows the ratio of medial occipital/
medial temporal lobe perfusion. This was lowest in MCI-LB, 
again being significantly different in comparison to controls, 
but not MCI-AD. As an indication of the tagging efficiency 
variablity, the measured signal in the occipital lobe in the 
perfusion weighted images (ie without normalisation by the 
cerebellum) was: Control 16.5 (SD 5.5), MCI-AD 18.4 (SD 
6.1), MCI-LB 14.4 (SD 4.5) arbitrary units.
For the voxelwise comparisons (Fig. 2, Table 3), the 
MCI-LB compared with the control group had significantly 
lower perfusion in the precuneus and superior parietal, pari-
etal-occipital, and fusiform gyrus occipito-temporal areas. 
We extracted the mean signal from the three significant clus-
ters (precuneus and superior parietal, inferior parietal, and 
occipito-temporal) to investigate correlations with clinical 
scales in the MCI-LB group.
There were no significant clusters in the voxelwise com-
parison between MCI-AD and either control or MCI-LB 
groups.
In the comparison of eyes open vs closed, as expected 
there was significantly higher perfusion in the primary visual 
cortex of the occipital lobe during the eyes open vs eyes 
closed period (Fig. 3). However, as can be seen in Table 4, 
there were no significant group differences in the change in 
perfusion to eyes opening. Table 4 also shows the occipi-
tal perfusion in the eyes closed state, showing a significant 
reduction in MCI-LB compared to the control group.
1288 Journal of Neurology (2021) 268:1284–1294
1 3
To investigate the extent to which the perfusion changes 
in the MCI-LB group were more marked in those subjects 
with a more robust LB disease phenotype, we compared 
those with two or fewer diagnostic features at baseline 
(including clinical features and abnormal MIBG or FP-
CIT) against those with more than 2 features. As shown 
in Fig. 4, compared to those with two or fewer diagnostic 
features, the MCI-LB participants with more diagnostic 
features had a significantly lower medial occipital/MTL 
perfusion ratio (0.992 SD 0.18 vs 1.180 SD 0.18; t = 3.01; 
p = 0.005). The PCC/ precuneus ratio was also greater 
(though not significantly) in this group (1.13 SD 0.17 vs 
1.03 SD 0.11; t = 2.00; p = 0.054). Although perfusion 
relative to cerebellum was lower in all the spm clusters in 
the MCI-LB group with more diagnostic features, this was 
not significant: superior parietal (2.78 SD 0.65 vs 3.2 SD 
Table 1  Subject demographics for those included in the analysis
Apart from age, sex and education, all reported statistical comparisons are between MCI-AD and MCI-LB
Values are mean (SD) or N (%)
UPDRS United Parkinson’s Disease Rating Scale (part III), MMSE mini mental state exam, ACE Addenbrooke’s cognitive exam, Epworth 
Epworth Sleepiness Scale, GDS Geriatric Depression Scale, IADL Instrumental Activities of Daily Living, NPI Neuropsychiatric Inventory, 
CDR Clinical dementia rating scale, RBD REM sleep behaviour disorder. FET Fisher’s exact test. WMH white matter hyperintensity. The statis-
tics on the WMH were performed on the log values
Control [N = 28] MCI-AD [N = 30] MCI-LB [N = 32] Comparison statistics
[MCI-AD vs -LB for 
clinical scores]






F2,87 = 1.41 p = 0.25









F2,84 = 2.87 p = 0.062
UPDRS Motor score 5.8 (4.4) 13.2 (11.2) 22.8 (14.5) t57.9 = − 2.93 p = 0.005
MMSE 28.4 (1.1) 26.7 (2.1) 26.5 (2.4) t59.7 = 0.34 p = 0.73
ACE Memory 22.5 (3.1) 18.0 (4.7) 20.0 (4.6) t59.5 = − 1.76 p = 0.084
ACE visuospatial 15.6 (0.7) 14.9 (1.3) 14.0 (2.0) t53.8 = 2.01 p = 0.049
ACE total 92.6 (4.1) 82.4 (8.7) 84.2 (9.2) t60.0 = − 0.80 p = 0.43
Epworth total 4.7 (3.0) 5.0 (4.6) 8.3 (4.4) t59.3 = − 2.88 p = 0.006
GDS 1.3 (1.9) 3.3 (2.4) 5.1 (4.2) t50.0 = − 2.07 p = 0.044
IADL 7.3 (1.3) 6.4 (1.4) t50.0 = 2.33 p = 0.024
CDR total 0.0 (0.0) 0.5 (0.0) 0.5 (0.1) t31.0 = 1.79 p = 0.083
NPI total 7.3 (8.8) 14.1 (11.3) t50.8 = − 2.46 p = 0.017
Cholinesterase Inhibitors 0/27 (0%) 6/28 (21%) 14/31 (45%) X2 = 2.71 p = 0.099
Antiparkinsonian drugs 0/27 (0%) 0/28 (0%) 4/31 (13%) FET, p = 0.11
Antidepressant drugs 3/27 (11%) 4/28 (14%) 13/31 (42%) FET, p = 0.024
Antipsychotic drugs 0/27 (0%) 0/28 (0%) 0/31 (0%) FET, p = 1.00
Anxiolytic drugs 1/27 (4%) 0/28 (0%) 1/31 (3%) FET, p = 1.00








t58.3 = 0.30 p = 0.76
Table 2  Perfusion ratio in 
posterior cingulate/precuneus 
(cingulate island) and medial 
occipital/medial temporal lobe
Tukey post hoc comparisons are shown in brackets





0.99 (0.11) 1.02 (0.12) 1.08 (0.15) F2,87 = 4.26 p = 0.017
(MCI-LB v control p = 0.014




1.22 (0.22) 1.20 (0.24) 1.08 (0.20) F2,87 = 3.81 p = 0.026
(MCI-LB v control p = 0.042
MCI-LB v MCI-AD p = 0.064)
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0.76; t = 1.67; p = 0.1), inferior parietal (3.38 SD 0.59 vs 
3.49 SD 0,70; t = 0.47, p = 0.6), occipito-temporal (2.26 
SD 0.40 vs 2.4 SD 0.60; t = 0.86; p = 0.4).
To see whether loss of cognitive abilities typical of 
LB disease were associated with perfusion loss, we also 
investigated associations between perfusion in these 
regions in the MCI-LB participants and the ACE Total 
score, as well as ACE visuospatial and memory composite 
score (Table 5) representing domains frequently affected in 
LBD and AD respectively. The parietal cluster perfusion 
Fig. 2  Significant perfusion reductions in MCI-LB relative to the control group. T  statistic map overlaid on study specific average structural 
scan. Results thresholded at p < 0.001 voxelwise
Table 3  Significant 
clusters for the comparison 
MCI-LB < control from the 
voxelwise analysis
A threshold of p < 0.001 uncorrected for multiple comparisons was applied voxelwise, and significant clus-
ters (p < 0.05) family wise error (FWE) corrected for multiple comparisons are reported
MNI Montreal Neurological Institute space
p value (FWE 
corrected)
Cluster size  (mm3) Representative coordinates in 
MNI space (x, y, z mm)
Location description
< 0.001 35,519 20, − 68, 40 Precuneus and superior parietal
21, − 58, 56
26, − 64, 28
0.001 5734 51, − 39, − 20 Inferior occipital/temporal 




< 0.001 7303 48, − 39, 32 Right inferior parietal
45, − 44, 26
50, − 39, 50
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correlated significantly with ACE visuospatial score, and 
tended to significance with ACE total and memory score; 
however, these were not significant after controlling for 
multiple comparisons.
Discussion
We found patterns of altered perfusion in MCI-LB which 
are similar to those seen in DLB, with reduction in poste-
rior parietal and occipital regions and a significantly lower 
medial occipital/MTL perfusion ratio compared with 
healthy controls, and evidence of the cingulate island sign, 
although this did not distinguish MCI-LB from MCI-AD.
The overall pattern of hypoperfusion in MCI-LB is 
very similar to that seen in DLB [3, 11, 24] albeit less pro-
nounced, with posterior reductions in perfusion, including 
the precuneus, inferior parietal, occipital lobe, and inferior 
temporal lobe, and relative sparing of the posterior cingulate 
gyrus (see Fig. 2). This implies that the typical perfusion 
deficits in DLB are present from an early stage, and encour-
ages the use of ASL or FDG-PET to identify those at risk 
of DLB. We saw some evidence (Table 4) that the perfusion 
in the precuneus and superior parietal lobe was reduced in 
those with worse cognition. These areas are affected in both 
Fig. 3  Areas where perfusion is greater during eyes open vs closed in the entire group. Statistic map thresholded at p = 0.05 voxelwise family 
wise error corrected. Overlaid on study specific average structural scan
Table 4  Percentage change 
in perfusion in primary 
visual areas on eyes opening 
compared between groups, and 
relative CBF in the eyes closed 
condition between groups
Tukey post hoc comparisons are shown in brackets
Control (N = 28) MCI-AD (N = 30) MCI-LB (N = 32) ANOVA statistics
CBF % change in 
medial occipital 
on opening eyes
10.30 (7.52) 7.04 (14.20) 9.11 (10.40) F2,87 = 0.65 p = 0.53
CBF eyes closed 
medial occipital 
/cerebellum
3.33 (0.38) 3.15 (0.48) 3.01 (0.45) F2,87 = 4.05 p = 0.021 
(MCI-LB v control 
p = 0.016
MCI-LB v MCI-AD 
p = 0.40)
Fig. 4  Medial occipital/medial temporal lobe perfusion ratio in the 
groups, with the probable MCI-LB group split by the number of core 
diagnostic features
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AD and DLB [2, 11, 24], and correlations between cognition 
and glucose metabolism in this region have likewise been 
reported in PD [12]. Reduced perfusion in the precuneus 
and adjacent parietal areas thus seems to relate to cognitive 
decline in general, rather than being specific to any particu-
lar disease.
The relative preservation of the posterior cingulate in 
DLB is well established, being visible using both FDG and 
ASL [3]. A study by Iizuka et al. [25] concluded that the 
cingulate island sign changed with LB disease progression 
in an inverted U shaped fashion, being most marked in those 
with an MMSE of 22 compared to those with higher or lower 
MMSE. In keeping with this, we found the ratio of posterior 
cingulate to precuneus was increased overall in MCI-LB, 
tending to be more so in those with more diagnostic features 
of LB disease. This finding supports the use of this ratio 
(or a visual rating scale assessment [26]) to identify those 
with more typical LB features. However, a recent review 
in MCI-LB [5] suggested that reduced posterior cingulate 
metabolism can occur in those who progress to DLB, and 
further work is needed to validate the use of posterior cin-
gulate preservation as a predictor of LB disease.
In our previous research in DLB with FDG-PET, we sug-
gested the use of the medial occipital to medial temporal 
lobe ratio to distinguish AD from DLB. Recent research in 
RBD (a frequent prodromal stage of Parkinson’s disease and 
DLB) has identified a pattern with (amongst other regions), 
relatively increased hippocampus, and decreased occipital 
glucose metabolism [27, 28] with similarities to the altera-
tions seen in DLB and PD [29] indicating that the pattern 
may be typical of LB disease. We found reductions in the 
occipital/MTL ratio in MCI-LB with more LB features, 
compared to controls, which in combination with the previ-
ous research suggests that this may be a useful measurement 
for identification of those with Lewy body disease.
We did not see any significant perfusion changes in 
MCI-AD compared to either the control group, or MCI-LB. 
Although several other reports have found perfusion differ-
ences in MCI-AD with ASL [8, 30, 31], others have not [32]. 
The extent to which hypoperfusion is demonstrated likely 
depends on disease severity, as well as the group homoge-
neity. Since all our MCI participants had to have some LB 
related symptoms (e.g. anosmia or visual disturbance), it 
may be that our MCI-AD group, whilst meeting standard 
diagnostic criteria, is more inclusive than those typically 
studied, and thus the perfusion values more varied than in 
a highly selected cohort. It could also be that the relatively 
small sample size of the study gave insufficient power to 
detect a difference.
As expected, we observed greater perfusion in the pri-
mary visual cortex in the eyes open vs eyes closed condition 
in all groups. In our paper [12] looking at glucose metabo-
lism in early stage PD we had observed a reduced metabo-
lism in the occipital lobe. The imaging in that study was 
performed with FDG injected in the eyes open state. We 
had hypothesised that in PD, increase in glucose metabo-
lism on eyes opening might be diminished due to reduced 
engagement with the visual environment. In the results pre-
sented here, the change in perfusion between eyes open and 
closed did not differ between groups. Furthermore, occipital 
hypoperfusion in MCI-LB relative to the control group was 
observed in the eyes closed perfusion data (see Table 5). 
This implies that the occipital hypometabolism and hypop-
erfusion seen in Lewy body disease is not related to retinal 
changes which are seen in LB disease [13]. Since there also 
appears to be relatively little pathology seen in the primary 
visual cortex in Lewy body disease [33, 34], this suggests 
that the metabolism changes are secondary to altered con-
nectivity with other brain regions.
Strengths of our study include the prospective design and 
consensus clinical assessment, along with the use of two 
imaging biomarkers (FP-CIT and MIBG), leading to strong 
confidence in the patient groups. We did not have specific 
biomarkers for AD, however, our MCI-AD group had nega-
tive FP-CIT and MIBG scans, both of which, individually, 
have good specificity for the diagnosis of DLB vs AD [38, 
39] which gives strong support to the MCI-AD diagnosis. 
Limitations of our study include that the ASL technique is 
sensitive to head movement, and we had to exclude a num-
ber of participants due to poor quality CBF images. Other 
studies have also excluded similar proportions of scans due 
to poor image quality [3, 8]. We also used relative rather 
than absolute CBF, as we did not acquire a suitable refer-
ence image, however Dolui et al. [8] found no difference in 
overall discriminatory ability between relative and absolute 
CBF. Due to changes in the vascular system, it could be that 
Table 5  Spearman correlations 
in MCI-LB patients of perfusion 
in the spm clusters and the two 
ROI ratios against ACE total 
score, ACE visuospatial and 
ACE memory subscore
* p < 0.05
ACE Total ACE visuospatial ACE memory
Parietal/cerebellum rho = 0.34; p = 0.055 rho = 0.39; p = 0.026* rho = 0.33; p = 0.064
Occipo-Temporal/cerebellum rho = 0.01; p = 0.97 rho = 0.28; p = 0.12 rho = 0.07; p = 0.70
Inferior Parietal/cerebellum rho = − 0.06; p = 0.74 rho = 0.08; p = 0.65 rho = − 0.06; p = 0.75
PCC/precuneus rho = 0.00; p = 0.98 rho = − 0.09; p = 0.63 rho = − 0.02; p = 0.90
Medial occipital/MTL rho = 0.17; p = 0.36 rho = 0.26; p = 0.16 rho = 0.11; p = 0.54
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both MCI-AD and MCI-LB have altered arterial transit time 
relative to controls [35]. The ASL imaging in this study was 
performed with a single fixed delay between the magnetic 
tagging of incoming blood and the acquisition of the image. 
This potentially leads to underestimation of perfusion if the 
delay is not well matched to the arterial transit time, however 
investigating this fully requires a long ASL protocol. It is 
possible that BOLD (blood oxygenation level dependent) 
changes may have influenced the ASL signal on eyes open-
ing. However, we used a short echo time and background 
suppression, which have been found to minimize the influ-
ence of BOLD on pCASL [36]. ASL relies on subtraction 
of two sets of images (control and tag), with the tag images 
having inflowing blood magnetically labelled. It is possible 
that mismatch between the control and tag images could 
lead to magnetisation transfer effects [37] and thus macro-
molecule differences (eg aggregated pathological proteins) 
may potentially have contributed to the signal.
Overall, we found perfusion changes in MCI-LB to be 
similar to the hypoperfusion/hypometabolism patterns seen 
in DLB but consistent with the earlier stage of disease these 
appear to be less prominent. Thus we found few significant 
differences between MCI-LB and MCI-AD perfusion pat-
terns, suggesting that ASL may be of limited utility diag-
nostically in mild cognitive impairment, though the medial 
occipital/MTL ratio might be of use and needs further 
exploration.
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